Compartir
Modern Dose-Finding Designs for Cancer Phase i Trials: Drug Combinations and Molecularly Targeted Agents (Springerbriefs in Statistics) (en Inglés)
Akihiro Hirakawa; Hiroyuki Sato; Takashi Daimon (Autor)
·
Springer
· Tapa Blanda
Modern Dose-Finding Designs for Cancer Phase i Trials: Drug Combinations and Molecularly Targeted Agents (Springerbriefs in Statistics) (en Inglés) - Akihiro Hirakawa; Hiroyuki Sato; Takashi Daimon
Libro Nuevo
Importado
Envío: 17 a 22 días háb.
S/ 453,38S/ 204,02
Costos de importación incluídos en el precio ✅
Reseña del libro "Modern Dose-Finding Designs for Cancer Phase i Trials: Drug Combinations and Molecularly Targeted Agents (Springerbriefs in Statistics) (en Inglés)"
This book deals with advanced methods for complex phase I and phase I/II dose-finding clinical trials with multiple drugs and outcomes in oncology. It provides not only methodological aspects of the dose-finding methods, but also software implementations and practical considerations in applying these complex methods to real cancer clinical trials. Thus, the book aims to furnish researchers in biostatistics and statistical science with a good summary of recent developments of complex dose-finding methods as well as providing practitioners in biostatistics and clinical investigators with advanced materials for designing, conducting, monitoring, and analyzing complex dose-finding trials. The topics in the book are mainly related to cancer clinical trials, but many of those topics are potentially applicable or can be extended to trials for other diseases. The focus is mainly on model-based dose-finding methods for two kinds of phase I trials. One is clinical trials with combinations of two agents. Development of dose-finding methods for two-agent combination trials requires reasonable models that can adequately capture joint toxicity probabilities for two agents, taking into consideration possible interactions of the two agents on toxicity probability such as synergistic or antagonistic effects. Another is clinical trials for evaluating both efficacy and toxicity outcomes in single- and two-agent combination trials. These methods are often applied to the phase I trials including molecularly targeted agents (MTAs) because the toxicity and efficacy for a MTA does not monotonically increase with dose, but the efficacy often increases initially with the dose and then plateaus. Successful software implementations for several dose-finding methods are introduced in the book, and their operating characteristics in practice are discussed. Recent applications of the above-mentioned adaptive dose-finding methods in drug developments are also provided.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.
✓ Producto agregado correctamente al carro, Ir a Pagar.
